nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—SLC22A8—urine—celiac disease	0.0525	0.0915	CbGeAlD
Dabrafenib—LIMK1—blood—celiac disease	0.0419	0.0731	CbGeAlD
Dabrafenib—LIMK1—Regulation of actin dynamics for phagocytic cup formation—MYO9B—celiac disease	0.0357	0.0837	CbGpPWpGaD
Dabrafenib—SIK1—connective tissue—celiac disease	0.0315	0.0549	CbGeAlD
Dabrafenib—LIMK1—Fcgamma receptor (FCGR) dependent phagocytosis—MYO9B—celiac disease	0.0269	0.0632	CbGpPWpGaD
Dabrafenib—SIK1—pancreas—celiac disease	0.0267	0.0465	CbGeAlD
Dabrafenib—CYP3A4—urine—celiac disease	0.026	0.0453	CbGeAlD
Dabrafenib—BRAF—blood—celiac disease	0.0259	0.0452	CbGeAlD
Dabrafenib—RAF1—connective tissue—celiac disease	0.0251	0.0437	CbGeAlD
Dabrafenib—RAF1—epithelium—celiac disease	0.0238	0.0415	CbGeAlD
Dabrafenib—SIK1—lymphoid tissue—celiac disease	0.023	0.0402	CbGeAlD
Dabrafenib—RAF1—smooth muscle tissue—celiac disease	0.0229	0.04	CbGeAlD
Dabrafenib—SIK1—blood—celiac disease	0.0217	0.0378	CbGeAlD
Dabrafenib—RAF1—pancreas—celiac disease	0.0212	0.037	CbGeAlD
Dabrafenib—BRAF—liver—celiac disease	0.0203	0.0353	CbGeAlD
Dabrafenib—RAF1—lymphoid tissue—celiac disease	0.0183	0.032	CbGeAlD
Dabrafenib—RAF1—digestive system—celiac disease	0.0181	0.0316	CbGeAlD
Dabrafenib—SLCO1B3—liver—celiac disease	0.0175	0.0304	CbGeAlD
Dabrafenib—RAF1—blood—celiac disease	0.0173	0.0301	CbGeAlD
Dabrafenib—SIK1—liver—celiac disease	0.017	0.0296	CbGeAlD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—RGS1—celiac disease	0.0169	0.0395	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of actin dynamics for phagocytic cup formation—FCGR2A—celiac disease	0.0148	0.0347	CbGpPWpGaD
Dabrafenib—SLCO1B1—digestive system—celiac disease	0.0136	0.0236	CbGeAlD
Dabrafenib—RAF1—liver—celiac disease	0.0135	0.0235	CbGeAlD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—ETS1—celiac disease	0.0134	0.0314	CbGpPWpGaD
Dabrafenib—SLCO1B1—blood—celiac disease	0.0129	0.0225	CbGeAlD
Dabrafenib—LIMK1—Fcgamma receptor (FCGR) dependent phagocytosis—FCGR2A—celiac disease	0.0112	0.0262	CbGpPWpGaD
Dabrafenib—SLCO1B1—liver—celiac disease	0.0101	0.0176	CbGeAlD
Dabrafenib—SLC22A8—blood—celiac disease	0.01	0.0175	CbGeAlD
Dabrafenib—RAF1—TCR Signaling Pathway—ICOS—celiac disease	0.00812	0.019	CbGpPWpGaD
Dabrafenib—CYP2C8—blood—celiac disease	0.00734	0.0128	CbGeAlD
Dabrafenib—ABCG2—blood—celiac disease	0.00714	0.0124	CbGeAlD
Dabrafenib—BRAF—Signaling events mediated by focal adhesion kinase—ETS1—celiac disease	0.00697	0.0163	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-2-alpha transcription factor network—ETS1—celiac disease	0.00671	0.0157	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00643	0.0151	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL21—celiac disease	0.00629	0.0148	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—MICA—celiac disease	0.00629	0.0148	CbGpPWpGaD
Dabrafenib—BRAF—Signaling events mediated by VEGFR1 and VEGFR2—PTPN2—celiac disease	0.00617	0.0145	CbGpPWpGaD
Dabrafenib—RAF1—IL-3 Signaling Pathway—CCR3—celiac disease	0.0059	0.0138	CbGpPWpGaD
Dabrafenib—CYP2C8—liver—celiac disease	0.00574	0.01	CbGeAlD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00569	0.0133	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.00561	0.0132	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—MYO9B—celiac disease	0.0056	0.0131	CbGpPWpGaD
Dabrafenib—ABCG2—liver—celiac disease	0.00558	0.00973	CbGeAlD
Dabrafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—celiac disease	0.00557	0.0131	CbGpPWpGaD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—HLA-DRB1—celiac disease	0.0054	0.0127	CbGpPWpGaD
Dabrafenib—CYP3A4—digestive system—celiac disease	0.00522	0.0091	CbGeAlD
Dabrafenib—CYP3A4—blood—celiac disease	0.00497	0.00867	CbGeAlD
Dabrafenib—ABCB1—epithelium—celiac disease	0.00486	0.00847	CbGeAlD
Dabrafenib—RAF1—Signaling events mediated by focal adhesion kinase—ETS1—celiac disease	0.00482	0.0113	CbGpPWpGaD
Dabrafenib—BRAF—B Cell Receptor Signaling Pathway—ETS1—celiac disease	0.00481	0.0113	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00475	0.0111	CbGpPWpGaD
Dabrafenib—RAF1—BCR signaling pathway—ETS1—celiac disease	0.00447	0.0105	CbGpPWpGaD
Dabrafenib—ABCB1—pancreas—celiac disease	0.00433	0.00754	CbGeAlD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00432	0.0101	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by VEGFR1 and VEGFR2—PTPN2—celiac disease	0.00427	0.01	CbGpPWpGaD
Dabrafenib—BRAF—Downstream signaling in naïve CD8+ T cells—CD8A—celiac disease	0.00402	0.00944	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.00395	0.00926	CbGpPWpGaD
Dabrafenib—CYP3A4—liver—celiac disease	0.00389	0.00678	CbGeAlD
Dabrafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—ETS1—celiac disease	0.00388	0.00911	CbGpPWpGaD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—CD4—celiac disease	0.00381	0.00894	CbGpPWpGaD
Dabrafenib—BRAF—PDGFR-beta signaling pathway—PTPN2—celiac disease	0.00379	0.00889	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN2—celiac disease	0.00375	0.00879	CbGpPWpGaD
Dabrafenib—ABCB1—lymphoid tissue—celiac disease	0.00374	0.00652	CbGeAlD
Dabrafenib—ABCB1—digestive system—celiac disease	0.0037	0.00644	CbGeAlD
Dabrafenib—BRAF—B Cell Receptor Signaling Pathway—CD79A—celiac disease	0.00367	0.0086	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—SH2B3—celiac disease	0.00353	0.00829	CbGpPWpGaD
Dabrafenib—ABCB1—blood—celiac disease	0.00352	0.00614	CbGeAlD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—TNFAIP3—celiac disease	0.00343	0.00804	CbGpPWpGaD
Dabrafenib—RAF1—BCR signaling pathway—CD79A—celiac disease	0.00341	0.008	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—ETS1—celiac disease	0.00333	0.00781	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00327	0.00766	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—MYO9B—celiac disease	0.00326	0.00765	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—IL17A—celiac disease	0.00323	0.00758	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—ICOS—celiac disease	0.00309	0.00725	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—ICOSLG—celiac disease	0.00295	0.00692	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00289	0.00678	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling in naïve CD8+ T cells—CD8A—celiac disease	0.00278	0.00653	CbGpPWpGaD
Dabrafenib—ABCB1—liver—celiac disease	0.00275	0.0048	CbGeAlD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.00274	0.00643	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—TNFRSF14—celiac disease	0.00263	0.00617	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—PTPN2—celiac disease	0.00262	0.00615	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—ETS1—celiac disease	0.0026	0.0061	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—MBL2—celiac disease	0.00257	0.00603	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—CD79A—celiac disease	0.00254	0.00595	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL12A—celiac disease	0.0025	0.00587	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—SH2B3—celiac disease	0.00247	0.00579	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00241	0.00566	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00233	0.00546	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—FCGR2A—celiac disease	0.00233	0.00545	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—TNFAIP3—celiac disease	0.00228	0.00535	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00219	0.00515	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—CD8A—celiac disease	0.00217	0.00509	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.00214	0.00501	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00203	0.00477	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MYO9B—celiac disease	0.00194	0.00454	CbGpPWpGaD
Dabrafenib—BRAF—Disease—LCT—celiac disease	0.00188	0.00442	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ICOS—celiac disease	0.00176	0.00414	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ARHGAP31—celiac disease	0.00174	0.00408	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL17A—celiac disease	0.00169	0.00397	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ICOSLG—celiac disease	0.00168	0.00394	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DPB1—celiac disease	0.00156	0.00366	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—LCT—celiac disease	0.00153	0.00359	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—TNFRSF14—celiac disease	0.0015	0.00352	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—MBL2—celiac disease	0.0015	0.00351	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CTLA4—celiac disease	0.00148	0.00347	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—CD80—celiac disease	0.00148	0.00346	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—PLEK—celiac disease	0.00141	0.00332	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—PTPN2—celiac disease	0.00137	0.00322	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—CD80—celiac disease	0.00137	0.00322	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—FCGR2A—celiac disease	0.00135	0.00318	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—TNFAIP3—celiac disease	0.00133	0.00312	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LCT—celiac disease	0.0013	0.00306	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DQA1—celiac disease	0.0013	0.00305	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—PTPN2—celiac disease	0.0013	0.00304	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—CD4—celiac disease	0.00125	0.00293	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—CD80—celiac disease	0.00122	0.00286	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DQB1—celiac disease	0.00122	0.00286	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ARHGAP31—celiac disease	0.0012	0.00282	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DPB1—celiac disease	0.0012	0.00282	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL10—celiac disease	0.00115	0.0027	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—CD80—celiac disease	0.00114	0.00268	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DPB1—celiac disease	0.00113	0.00266	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MYO9B—celiac disease	0.00113	0.00265	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.0011	0.00258	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—CD80—celiac disease	0.00109	0.00256	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CTLA4—celiac disease	0.00108	0.00252	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—CD80—celiac disease	0.00107	0.00252	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICOS—celiac disease	0.00107	0.00251	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—CD80—celiac disease	0.00107	0.00251	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MYO9B—celiac disease	0.00105	0.00247	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—LCT—celiac disease	0.00103	0.00241	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD79A—celiac disease	0.00103	0.00241	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—CD80—celiac disease	0.00103	0.00241	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—CD80—celiac disease	0.00102	0.00239	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICOSLG—celiac disease	0.00102	0.00239	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—CD80—celiac disease	0.00102	0.00238	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—CD80—celiac disease	0.00101	0.00237	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQA1—celiac disease	0.001	0.00235	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—LCT—celiac disease	0.000952	0.00223	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—CD80—celiac disease	0.000951	0.00223	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—CD80—celiac disease	0.000951	0.00223	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—CD80—celiac disease	0.000951	0.00223	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DQA1—celiac disease	0.000947	0.00222	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—CD80—celiac disease	0.000943	0.00221	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQB1—celiac disease	0.000938	0.0022	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—CD80—celiac disease	0.000937	0.0022	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—CD80—celiac disease	0.000934	0.00219	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—CD80—celiac disease	0.00093	0.00218	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DRB1—celiac disease	0.000926	0.00217	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TAGAP—celiac disease	0.000914	0.00214	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TNFRSF14—celiac disease	0.000909	0.00213	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MBL2—celiac disease	0.000889	0.00209	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—SH2B3—celiac disease	0.000888	0.00208	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DQB1—celiac disease	0.000886	0.00208	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CD80—celiac disease	0.000855	0.00201	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CD80—celiac disease	0.000843	0.00198	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD8A—celiac disease	0.000827	0.00194	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—CD4—celiac disease	0.000816	0.00191	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—FCGR2A—celiac disease	0.000804	0.00189	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—RGS1—celiac disease	0.000796	0.00187	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—TNFAIP3—celiac disease	0.000789	0.00185	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MYO9B—celiac disease	0.000729	0.00171	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DRB1—celiac disease	0.000713	0.00167	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RGS1—celiac disease	0.000679	0.00159	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DRB1—celiac disease	0.000674	0.00158	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—CD80—celiac disease	0.000648	0.00152	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DPB1—celiac disease	0.000647	0.00152	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TAGAP—celiac disease	0.000632	0.00148	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD80—celiac disease	0.000622	0.00146	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCR4—celiac disease	0.000615	0.00144	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CTLA4—celiac disease	0.000614	0.00144	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LCT—celiac disease	0.000591	0.00139	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD79A—celiac disease	0.000585	0.00137	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DQA1—celiac disease	0.00054	0.00127	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCR4—celiac disease	0.000525	0.00123	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCR3—celiac disease	0.000523	0.00123	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MBL2—celiac disease	0.000518	0.00121	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LCT—celiac disease	0.000515	0.00121	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DQB1—celiac disease	0.000505	0.00118	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD4—celiac disease	0.000475	0.00111	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD8A—celiac disease	0.000472	0.00111	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RGS1—celiac disease	0.00047	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FCGR2A—celiac disease	0.000468	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TNFAIP3—celiac disease	0.00046	0.00108	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PTPN2—celiac disease	0.000449	0.00105	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCR3—celiac disease	0.000446	0.00105	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SH2B3—celiac disease	0.000435	0.00102	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DPB1—celiac disease	0.000393	0.000921	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DRB1—celiac disease	0.000384	0.000901	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTLA4—celiac disease	0.000372	0.000873	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CD80—celiac disease	0.00037	0.000867	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCR4—celiac disease	0.000363	0.000852	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD79A—celiac disease	0.000355	0.000833	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD80—celiac disease	0.000355	0.000832	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DQA1—celiac disease	0.000328	0.000768	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LCT—celiac disease	0.000317	0.000743	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCR3—celiac disease	0.000309	0.000724	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DQB1—celiac disease	0.000306	0.000719	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SH2B3—celiac disease	0.000301	0.000706	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CD80—celiac disease	0.000287	0.000674	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD8A—celiac disease	0.000286	0.000671	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CD4—celiac disease	0.000282	0.000662	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD4—celiac disease	0.000271	0.000635	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DRB1—celiac disease	0.000233	0.000546	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CD4—celiac disease	0.000219	0.000514	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD80—celiac disease	0.000215	0.000505	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CD80—celiac disease	0.000201	0.000472	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CD80—celiac disease	0.000199	0.000466	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD4—celiac disease	0.000164	0.000385	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CD4—celiac disease	0.000152	0.000356	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CD80—celiac disease	0.000139	0.000326	CbGpPWpGaD
